Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid. 2021

Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
Department of Chronic Diseases, Metabolism & Ageing (CHROMETA), Laboratory of Respiratory Diseases & Thoracic Surgery (BREATHE), UZ/KU Leuven, Leuven, Belgium.

In recent years, the utility of vascular complement factor 4d (C4d) deposition as diagnostic tool for antibody mediated rejection (AMR) after lung transplantation, has become a controversial issue. We aimed to pinpoint the problematic nature of C4d as biomarker with a simple experiment. We quantified C4d in broncho-alveolar lavage (BAL) of lung transplant patients with diverse post-transplant complications in 3 different settings of clinically clear cases of: 1/ chronic lung allograft dysfunction (CLAD); 2/ acute complications acute rejection (AR), lymphocytic bronchiolitis (LB), antibody-mediated rejection (AMR) and respiratory infection (INF); 3/ patients with parallel C4d immunostaining and Anti-HLA. All groups were compared to BAL of stable patients. C4d was measured via standard ELISA. C4d was increased in CLAD, predominantly in RAS (p = 0.0026) but not in BOS (p = 0.89). C4d was increased in all acute events, AR (p = 0.0025), LB (p < 0.0001), AMR (p = 0.0034), infections (p < 0.0001). In patients with parallel C4d immunostaining and serum HLA antibodies, C4d was increased in C4d-/HLA- (p = 0.0011); C4d-/HLA+ (p = 0.013); HLA+/C4d + (p = 0.0081). A correlation of systemic C-reactive protein (CRP) with C4d was found in all patients (r = 0.49; p < 0.0001). We hypothesize that free C4d in BAL may only be representative of a general immune response in the transplanted lung.

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females

Related Publications

Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
October 2009, Transplantation proceedings,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
January 2015, Cancer genomics & proteomics,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
August 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
February 1991, The Annals of thoracic surgery,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
September 2009, Proteomics. Clinical applications,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
November 1992, Kyobu geka. The Japanese journal of thoracic surgery,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
December 2010, Transplantation proceedings,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
March 1990, Nihon rinsho. Japanese journal of clinical medicine,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
January 1992, Nihon Kyobu Shikkan Gakkai zasshi,
Tobias Heigl, and Berta Saez-Gimenez, and Anke Van Herck, and Janne Kaes, and Annelore Sacreas, and Hanne Beeckmans, and Gene P L Ambrocio, and Hanneke Kwakkel-Van Erp, and Sofie Ordies, and Arno Vanstapel, and Stijn E Verleden, and Arne P Neyrinck, and Laurens J Ceulemans, and Dirk E Van Raemdonck, and Erik Verbeken, and Geert M Verleden, and Robin Vos, and Bart Vanaudenaerde
January 1985, The Journal of heart transplantation,
Copied contents to your clipboard!